http://www.nasdaq.com/article/novavax-reports-positive-top-line-results-from-two-phase-1-trials-of-pandemic-influenza-vaccine-20121017-01053#.UH_CaW8QYsI
Posted by Rob LW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment